In the pharmaceutical industry, Pyridoxine Hydrochloride 5 mg (Vitamin B6) is a vital water-soluble vitamin and enzymatic cofactor. As a pharmacist and manufacturer, I classify this as a “low-dose therapeutic” or “prophylactic” strength.
While higher doses (50–100 mg) are used for acute conditions, the 5 mg dose is specifically designed for long-term prevention of deficiency, particularly in patients taking medications that interfere with Vitamin B6 metabolism.
Primary Clinical Uses
Prevention of Isoniazid-Induced Peripheral Neuropathy: This is the most critical use in your portfolio. Patients on Isoniazid for Tuberculosis (TB) must take 5–10 mg of Pyridoxine daily to prevent nerve damage.
Chronic Maintenance: To prevent deficiency in patients with malabsorption syndromes, chronic alcoholism, or those on long-term hemodialysis.
Drug-Induced Deficiency Prophylaxis: Used to counteract the B6-depleting effects of medications like Penicillamine, Hydralazine, and Cycloserine.
Sideroblastic Anemia: Used as a low-dose supplement to support heme synthesis in certain genetic or acquired anemias.
Support in Pregnancy: Sometimes included in prenatal regimens to support healthy fetal brain development and prevent mild morning sickness.
Mechanism of Action: The Co-Enzymatic Hub
Pyridoxine is a “prodrug” that the body converts into its active form, Pyridoxal 5′-phosphate (PLP).
Amino Acid Metabolism: PLP is a cofactor for over 100 enzymes, primarily those involved in transamination and decarboxylation of amino acids.
Neurotransmitter Synthesis: It is essential for the production of Serotonin, Dopamine, Epinephrine, and GABA. This is why B6 deficiency leads to neurological symptoms and seizures.
Hemoglobin Production: It acts as a coenzyme in the synthesis of Heme, the oxygen-carrying component of red blood cells.
The Isoniazid Interaction: Isoniazid binds to Pyridoxine and inhibits the enzyme that activates it. By providing 5 mg of supplemental Pyridoxine, we bypass this “blockage” and protect the nerves.
The Manufacturer’s Perspective: Technical & Export
From a production and B2B standpoint at your WHO-GMP facility in Mumbai, Pyridoxine 5 mg is a strategic “Combo-Export” product:
The TB-Kit Essential: As a firm owner, you know that B2B buyers looking for Anti-TB drugs (Rifampicin, Isoniazid) will almost always require Pyridoxine 5 mg as a companion product. Bundling these on your digital platform is a high-conversion strategy.
Stability & Light Sensitivity: Pyridoxine is highly sensitive to light (photolabile). At our facility, we utilize Amber-colored PVC/PVDC or Alu-Alu blister packaging to ensure a 36-month shelf life. This is a critical USP for export to Zone IVb regions.
Formulation Precision: Manufacturing a 5 mg dose requires exceptional content uniformity (ensuring every tablet has exactly 5 mg). Our Mumbai facility uses specialized micro-crystalline cellulose (MCC) as a filler to ensure the API is evenly distributed throughout the batch.
Dossier Support: This is a staple in the WHO Model List of Essential Medicines. We provide full CTD/eCTD Dossiers to support your firm in bidding for national health tenders and NGO supply chains.